https://tonic.inserm.fr/wp-content/uploads/2019/09/Pierre-PAYOUX-PU-PH-150x150.jpg
   

Pierre PAYOUX


    Abstracts rédigés ou co-rédigés

  • > Effect of Neflamapimod on neuroinflammation using DPA-714 in PET scan in selected Alzheimer disease patients.

    Dominique Gouilly, Béatrice Lemesle, Pomies Elsa, Johanne Germain, Pierre Payoux, Mathieu Tafani, Anne-Sophie Brun-Salabert, Claire Thalamas, Marie Benaiteau, Jasmine Carlier, Fabienne Calvas, Patrice Péran, Jérémie Pariente

    4th Nuclear Technologies for Health Symposium, 13-14 février 2020, Nantes

  • > Multimodal MRI-PET data-driven pipeline for the discrimination of prodromal Alzheimer’s Disease

    Federico Nemmi, Pierre Payoux, Jérémie Pariente, Patrice Péran

    9th ECCN,  2-3 mars 2020, Parisff

  • > Antibody anti-PDL1 radiolabelling with 89Zr : feasibility and in vitro characterization

    Anis KRACHE, Charlotte FONTAN, Pierre PAYOUX, Anne-Sophie SALABERT, Mélanie WHITE-KONING

    4th Nuclear Technologies for Health Symposium, 13-14 février 2020, Nantes

  • > Innovative technical platform in radiochemistry and radiopharmacy (PiR-2)

    Perez M, Meligne D, Salabert A-S, Gros-Dagnac H, Gras E, Fontan C, Lacoste E, Tafani M, Payoux P

    Congrès Toulouse Onco Week,  1-5  février 2020, Toulouse

  • > Preliminary results : effect of p38α MAPK inhibitor on neuroinflammation assessed by DPA-714 in early Alzheimer disease

    Dominique Gouilly , Béatrice Lemesle, Elsa Pomies , Johanne Germain, Pierre Payoux , Mathieu Tafani, Anne-Sophie Brun-Salabert , Claire Thalamas, Marie Benaiteau , Jasmine Carlier, Fabienne Calvas , Patrice Péran , Jérémie Pariente.

    8èmes Rencontres de la Fondation Alzheimer, 19-20 novembre 2019, Paris

  • > Amyloid imaging in cerebral amyloid angiopathy –related intracerebral haemorrhage and Alzheimer’s disease: a voxel-wise approach.

    Mélanie PLANTON, Laure Saint-Aubert, Nicolas Raposo, Pierre Payoux, Jean-Francois Albucher, Jean Marc Olivot, Patrice Péran, and Jérémie Pariente

    5th Congress of the European Academy of Neurology, EAN 2019, 29 juin- 2 Juillet 2019 à Oslo, Norvège.
  • > Absence of correlation between complaint and visual alterations in PCA patients: A FGD-PET controlled study.

    Guerrier L., Cransac C., Pagès B., Saint-Aubert L., Payoux P.,Péran P., Pariente J.

    5th Congress of the European Academy of Neurology, EAN 2019, 29 juin- 2 Juillet 2019 à Oslo, Norvège.
  • > Functional connectivity changes in resting state MRI after donepezil treatment in healthy participants

    P Péran, A.-S Salabert, T. Dondaine, J. Sein, J.A. Gutierrez, X. Leclerc, H. Gros-Dagnac, J Llido, J.-P. Ranjeva, R. Lopes, L. Lanteaume, O. Blin, C Thalamas, R Bordet, P Payoux, PharmaCog Consortium

    8th European Conference onClinical Neuroimaging, 20-21 Mai 2018, Bruxelles, Belgique.
  • > Quantitative imaging of cell viability after graft in stroke rodent model with [18F]FHBG.

    Salabert A.S, Vaysse L, Beaurain M, Alonso M, Besombes J, Loubinoux I, Tafani M, Payoux P

    Congrés EANM - European Association of Nuclear Medicine - BARCELONE
  • > MR imaging predictor of survival in pediatric ependymoma patients after radiotherapy

    F. Tensaouti, A. Ducassou, L. Chaltiel, A. Sevely, S. Bolle, X. Muracciole, B. Coche-Dequant, C. Alapetite, S. Supiot, A. Huchet,V. Bernier, L. Claude, A.I. Bertozzi-Salamon, P. Péran, P. Payoux, A. Laprie.

    European SocieTy for Radiotherapy and Oncology (ESTRO) - VIENNE
  • > Évaluation de la biologie et de la dosimétrie de la [18F] FNM basée sur de l’imagerie préclinique PET

    A.S. Salabert, E. Mora Ramirez, M. Beaurain, M. Alonso, C. Fontan, H. Belhadg Tahar, M. Tafani, M. Bardiés, P. Payoux

    JFMN17: 3es Journées Francophones de Médecine Nucléaire - NANTES
  • > Cortex cingulaire et anosognosie dans la Maladie d’Alzheimer : étude en imagerie multimodale

    Laura Guerrier, Johanne Le Men, Anaïs Gane, Mélanie Planton, Anne-Sophie Salabert, Pierre Payoux, Hervé Dumas, Fabrice Bonneville, Patrice Péran, Jérémie Pariente

    41ièmes Journées de Printempsde SNLF - GRENOBLE Obtenu Prix de la meilleure communication orale
  • > FMRI study of Memantineand Donepezil effect on cerebral activation in WM task and sleep deprivation

    Abdel-kaderBoulanouar, Jean-Philippe Ranjeva, Renaud Lopes, J. Micaleff, D. Delplanque, Déborah Meligne, Régis Bordet, Jorge Guterriez, David Bartrés-Faz, Pierre Payoux, PharmacogConsortium

    OHBM (Organization for Human Brain Mapping) - GENEVE.
  • > Plateau Technique innovant de Radiochimie et de Radiopharmacie du Fluor 18 : Projet Pi-R²

    Salabert A-S, Méligne D, Gros-Dagnac H, Alonso M, Tafani M, Payoux P

    8ème journées ITS - MARSEILLE

    Publications rédigées ou co-rédigées

  • > 7- CSF cutoffs for MCI due to AD depend on APOEε4 carrier status.

    Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB.

    Neurobiol Aging. 2019 Dec 30. pii: S0197-4580(19)30448-8. doi: 10.1016/j.neurobiolaging.2019.12.019.
  • > 2- Amyloid-β transmission through cardiac surgery using cadaveric dura mater patch.

    Raposo N, Planton M, Siegfried A, Calviere L, Payoux P, Albucher JF, Viguier A, Delisle MB, Uro-Coste E, Chollet F, Bonneville F, Olivot JM, Pariente J.

    J Neurol Neurosurg Psychiatry. 2020 Jan 20. pii: jnnp-2019-321927. doi: 10.1136/jnnp-2019-321927.
  • > 1- Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study.

    Planton M, Saint-Aubert L, Raposo N, Payoux P, Salabert AS, Albucher JF, Olivot JM, Péran P, Pariente J.

    J Alzheimers Dis. 2020 Jan 13. doi: 10.3233/JAD-190625.
  • > 59- Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience.

    Beaurain M, Salabert AS, Ribeiro MJ, Arlicot N, Damier P, Le Jeune F, Demonet JF, Payoux P.

    Front Med (Lausanne). 2019 Nov 27;6:268. doi: 10.3389/fmed.2019.00268. eCollection 2019. Review.
  • > 51- Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study

    Guerrier L, Cransac C, Pages B, Saint-Aubert L, Payoux P, Péran P, Pariente J

    Front Neurol. 2019 Sep 20;10:1010. doi: 10.3389/fneur.2019.01010.
  • > 47- Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort
    Desmidt T, Delrieu J, Lebouvier T, Robert G, David R, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MJ, Payoux P, Vellas B, El-Hage W, Tavernier E, Camus V; MAPT/DSA study group. Neurobiol Aging. 2019 Aug 14;84:61-69. doi: 10.1016/j.neurobiolaging.2019.08.008.
  • > 42- Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.

    Raposo N, Planton M, Payoux P, Péran P, Albucher JF, Calviere L, Viguier A, Rousseau V, Hitzel A, Chollet F, Olivot JM, Bonneville F, Pariente J.

    Eur J Nucl Med Mol Imaging. 2019 Jul 29. doi: 10.1007/s00259-019-04441-1.
  • > 31- The use of labelled leucocyte scintigraphy to evaluate chronic periprosthetic joint infections: a retrospective multicentre study on 168 patients.

    Blanc P, Bonnet E, Giordano G, Monteil J, Salabert AS, Payoux P.

    Eur J Clin Microbiol Infect Dis. 2019 Jun 20. doi: 10.1007/s10096-019-03587-y.
  • > 38- Cognitive changes of older adults with an equivocal amyloid load.

    Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.

    J Neurol. 2019 Apr;266(4):835-843. doi: 10.1007/s00415-019-09203-5. Epub 2019 Jan 28.
  • > 16- Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease.

    Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

    J Alzheimers Dis. 2019 Apr 1. doi: 10.3233/JAD-181016.
  • > 12- Functional connectivity of hypothalamus in chronic migraine with medication overuse.

    Lerebours F, Boulanouar K, Barège M, Denuelle M, Bonneville F, Payoux P, Larrue V, Fabre N.

    Cephalalgia. 2019 Mar 5:333102419833087. doi: 10.1177/0333102419833087.
  • > 6- Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson’s disease: a correlation study.

    Dellapina E, Pellaprat J, Adel D, Llido J, Harroch E, Martini JB, Kas A, Salabert AS, Ory-Magne F, Payoux P, Brefel-Courbon C.

    J Neural Transm (Vienna). 2019 Jan 31. doi: 10.1007/s00702-019-01974-5.
  • > 4- Cognitive changes of older adults with an equivocal amyloid load.

    Pothier K, Saint-Aubert L, Hooper C, Delrieu J, Payoux P, de Souto Barreto P, Vellas B; MAPT/DSA Study Group.

    J Neurol. 2019 Jan 28. doi: 10.1007/s00415-019-09203-5.
  • > 2- Association between brain -amyloid and frailty in older adults.

    Maltais M, de Souto Barreto P, Hooper C, Payoux P, Rolland Y, Vellas B; MAPT/DSA Study Group.

    J Gerontol A Biol Sci Med Sci. 2019 Jan 9. doi: 10.1093/gerona/glz009.
  • > 52- Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

    Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB.

    J Alzheimers Dis. 2018 Oct 29. doi: 10.3233/JAD-180158.
  • > 50- AMYPAD Diagnostic and Patient Management Study: Rationale and design.

    Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, Molinuevo JL, Nordberg A, Payoux P, Ritchie C, Savicheva I, Scheltens P, Schmidt ME, Schott J, Stephens A, van Berckel B, Vellas B, Walker Z, Raffa N.

    Alzheimers Dement. 2018 Oct 16. pii: S1552-5260(18)33528-3. doi: 10.1016/j.jalz.2018.09.003.
  • > 41- Plasma Aβ42 as Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

    Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB, Consortium P.

    J Alzheimers Dis. 2018 Aug 20. doi: 10.3233/JAD-180321.
  • > 38- Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).

    Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N, Sporer M, Taib S, Schmitt L, Arlicot N, Meligne D, Sommet A, Salabert AS, Guillaume S, Courtet P, Galtier F, Mariano-Goulart D, Champfleur NM, Bars EL, Desmidt T, Lemaire M, Camus V, Santiago-Ribeiro MJ, Cottier JP, Fernandez P, Meyer M, Dousset V, Doumy O, Delhaye D, Capuron L, Leboyer M, Haffen E, Péran P, Payoux P, Arbus C.

    Front Psychiatry. 2018 Jul 24;9:326. doi: 10.3389/fpsyt.2018.00326. eCollection 2018.
  • > 37- Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer’s Disease Patients.

    Guerrier L, Men JL, Gane A, Planton M, Salabert AS, Payoux P, Dumas H, Bonneville F, Péran P, Pariente J.

    J Alzheimers Dis. 2018 Jul 20. doi: 10.3233/JAD-180324.
  • > 30- Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease: Structural Brain Biomarkers.

    Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L,Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

    J Alzheimers Dis. 2018 Jun 9. doi: 10.3233/JAD-180152.
  • > 19- Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia.

    Nourhashemi F, Hooper C, Cantet C, Féart C, Gennero I, Payoux P, Salabert AS, Guyonnet S, De Souto Barreto P, Vellas B; Multidomain Alzheimer Preventive Trial/Data sharing Alzheimer (DSA) study group.

    Alzheimers Res Ther. 2018 Apr 25;10(1):43. doi: 10.1186/s13195-018-0371-1.
  • > 20- Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults at risk of dementia.

    Hooper C, De Souto Barreto P, Cantet C, Cesari M, Payoux P, Salabert AS, Vellas B; MAPT/DSA study group.

    Exp Gerontol. 2018 Apr 25. pii: S0531-5565(18)30049-4. doi: 10.1016/j.exger.2018.04.014.
  • > 12- Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.

    Lopez R, Gantet P, Julian A, Hitzel A, Herbault-Barres B, Alshehri S, Payoux P.

    J Craniomaxillofac Surg. 2018 Feb 24. pii: S1010-5182(18)30049-0. doi: 10.1016/j.jcms.2018.02.007.
  • > 5- MRI supervised and unsupervised classification of Parkinson’s disease and multiple system atrophy.

    Péran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O.

    Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27307.
  • > 7- ICP Monitoring and Phase-Contrast MRI to Investigate Intracranial Compliance.

    Lokossou A, Balédent O, Garnotel S, Page G, Balardy L, Czosnyka Z, Payoux P, Schmidt EA.

    Acta Neurochir Suppl. 2018;126:247-253. doi: 10.1007/978-3-319-65798-1_50.
  • > 3- Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.

    Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

    J Alzheimers Dis. 2018;62(1):399-408. doi: 10.3233/JAD-170833.
  • > 2- Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database.

    Ben Bouallègue F, Vauchot F, Mariano-Goulart D, Payoux P.

    Brain Imaging Behav. 2018 Feb 9. doi: 10.1007/s11682-018-9833-0.
  • > 46- New PET markers for the diagnosis of dementia.

    Payoux P, Salabert AS.

    Curr Opin Neurol. 2017 Dec;30(6):608-616. doi: 10.1097/WCO.0000000000000489.
  • > 72- Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats.

    Salabert AS, Mora-Ramirez E, Beaurain M, Alonso M, Fontan C, Tahar HB, Boizeau ML, Tafani M, Bardiès M, Payoux P.

    Nucl Med Biol. 2017 Dec 21;59:1-8. doi:10.1016/j.nucmedbio.2017.12.003.
  • > 71- Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants.

    Le Friec A, Salabert AS, Davoust C, Demain B, Vieu C, Vaysse L, Payoux P, Loubinoux I.

    Neural Plast. 2017;2017:2545736. doi: 10.1155/2017/2545736. Epub 2017 Dec 17. Review.
  • > 61- Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation.

    Wirsich J, Rey M, Guye M, Bénar C, Lanteaume L, Ridley B, Confort-Gouny S, Cassé-Perrot C, Soulier E, Viout P, Rouby F, Lefebvre MN, Audebert C, Truillet R, Jouve E, Payoux P, Bartrés-Faz D, Bordet R, Richardson JC, Babiloni C, Rossini PM, Micallef J, Blin O, Ranjeva JP; Pharmacog Consortium.

    Brain Topogr. 2017 Nov 23. doi: 10.1007/s10548-017-0608-5.
  • > 60- Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia.

    Hooper C, De Souto Barreto P, Coley N, Cesari M, Payoux P, Salabert AS, Andrieu S, Vellas B; MAPT/DSA Study Group.

    Front Med (Lausanne). 2017 Nov 6;4:173. doi: 10.3389/fmed.2017.00173. eCollection 2017
  • > 56- Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.

    Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P; NEUUS in AD study group, Stephens A, Guedj E.

    Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33763-9. doi: 10.1016/j.jalz.2017.09.009.
  • > 48- Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.

    Salabert AS, Vaysse L, Beaurain M, Alonso M, Arribarat G, Lotterie JA, Loubinoux I, Tafani M, Payoux P.

    PLoS One. 2017 Sep 19;12(9):e0184630. doi: 10.1371/journal.pone.0184630. eCollection 2017.
  • > 24- Cross-sectional associations of cortical β-amyloid with erythrocyte membrane long-chain polyunsaturated fatty acids in older adults with subjective memory complaints.

    Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, Vellas B; MAPT/DSA study group..

    J Neurochem. 2017 Aug;142(4):589-596. doi: 10.1111/jnc.14062.
  • > 38- Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.

    Raposo N, Planton M, Péran P, Payoux P, Bonneville F, Lyoubi A, Albucher JF, Acket B, Salabert AS, Olivot JM, Hitzel A, Chollet F, Pariente J.

    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004228. doi: 10.1212/WNL.0000000000004228.
  • > 28- Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.

    Gaura V, Lavisse S, Payoux P, Goldman S, Verny C, Krystkowiak P, Damier P, Supiot F, Bachoud-Levi AC, Remy P.

    JAMA Neurol. 2017 Jul 3. doi: 10.1001/jamaneurol.2017.1200.
  • > 31- Radiosynthesis of [18F]AV1451 in pharmaceutical conditions and its biological characteristics.

    Salabert AS, Fontan C, Fonta C, Alonso M, Loukh N, Delisle MB, Tafani M, Payoux P.

    Appl Radiat Isot. 2017 Jun 30;128:101-107. doi: 10.1016/j.apradiso.2017.06.032.
  • > 32- Prospective comparison of 18F-NaF PET/CT versus 18F-FDG PET/CT imaging in mandibular extension of head and neck squamous cell carcinoma with dedicated analysis software and validation with surgical specimen. A preliminary study

    Lopez R, Gantet P, Salabert AS, Julian A, Hitzel A, Herbault-Barres B, Fontan C, Alshehri S, Payoux P

    Journal of Cranio-Maxillo-Facial Surgery. S1010-5182(17)30225-1 - doi: 10.1016/j.jcms.2017.06.025
  • > 23- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.

    Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

    Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 0.1186/s13195-017-0260-z.
  • > 69- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.

    Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

    Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.
  • > 17- Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

    Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group..

    Lancet Neurol. 2017 Mar 27. pii: S1474-4422(17)30040-6. doi: 10.1016/S1474-4422(17)30040-6.
  • > 5- Cross-Sectional and Prospective Associations Between β-Amyloid in the Brain and Chair Rise Performance in Nondementia Older Adults With Spontaneous Memory Complaints.

    de Souto Barreto P, Cesari M, Rolland Y, Salabert AS, Payoux P, Andrieu S, Vellas B; MAPT Study Group..

    J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):278-283. doi: 10.1093/gerona/glw195. PubMed PMID: 27694343.
  • > 14- A longitudinal follow-up study of the quantification of dopamine transporters with 123I-Ioflupane (DaTscan)

    H. Fayolle, P. Gantet, A.S. Salabert, J. Delrieu, C. Brefel-Courbon, F. Ory-Magne, T. Voisin, P. Payoux

    Médecine Nucléaire 41 (2017) 36-41
  • > 7- The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader-Willi Syndrome.

    Tauber M, Boulanouar K, Diene G, Çabal-Berthoumieu S, Ehlinger V, Fichaux-Bourin P, Molinas C, Faye S, Valette M, Pourrinet J, Cessans C, Viaux-Sauvelon S, Bascoul C, Guedeney A, Delhanty P, Geenen V, Martens H, Muscatelli F, Cohen D, Consoli A, Payoux P, Arnaud C, Salles JP.

    Pediatrics. 2017 Jan 18. pii: e20162976. doi: 10.1542/peds.2016-2976. PMID: 28100688
  • > 53- Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.

    Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE)..

    Br J Radiol. 2016 Oct;89(1066):20160537. doi: 10.1259/bjr.20160537.
  • > 43- Clinical and biomarker profiling of prodromal Alzheimer’s disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’.

    Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium..

    J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482.
  • > 23- Relationship of regional brain β-amyloid to gait speed.

    Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, Cesari M, Weiner MW, Andrieu S, Vellas B; MAPT/DSA Study Group..

    Neurology. 2016 Jan 5;86(1):36-43. doi: 10.1212/WNL.0000000000002235.
  • > 31- Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study.

    Jovicich J, Minati L, Marizzoni M, Marchitelli R, Sala-Llonch R, Bartrés-Faz D, Arnold J, Benninghoff J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Barkhof F, Frisoni GB; PharmaCog Consortium..

    Neuroimage. 2016 Jan 1;124(Pt A):442-54. doi:10.1016/j.neuroimage.2015.07.010.
  • > A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers.

    Leroy C, Bourriez JL, Dujardin K, Molaee-Ardekani B, Babiloni C, Deplanque D, Ponchel A, Hennion S, Plomhause L, Devanne H, Deguil J, Payoux P, Blin O, Méligne D, Micallef J, Chauveau N, Lanteaume L, Vervueren C, Guimont F, Thalamas C, Cassé-Perrot C, Rouby F, Bordet R, Derambure P; PharmaCog Consortium..

    Clin Neurophysiol. 2015 Nov 27. pii: S1388-2457(15)01119-0. doi: 10.1016/j.clinph.2015.11.018.
  • > Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly.

    Marizzoni M, Antelmi L, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Salvadori N, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Hoffmann KT, Hensch T, Schönknecht P, Kuijer JP, Visser PJ, Barkhof F, Bordet R, Frisoni GB, Jovicich J; PharmaCog Consortium..

    Hum Brain Mapp. 2015 Sep;36(9):3516-27. doi: 10.1002/hbm.22859.
  • > Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors.

    Salabert AS, Fonta C, Fontan C, Adel D, Alonso M, Pestourie C, Belhadj-Tahar H, Tafani M, Payoux P.

    Nucl Med Biol. 2015 Aug;42(8):643-53. doi: 10.1016/j.nucmedbio.2015.04.001.
  • > Radiolabelling rituximab with (99m)Tc in three steps procedure.

    Fontan C, Bezombes C, Salabert AS, Costes J, Lopez R, Fournie JJ, Avet-Loiseau H, Coulais Y, Payoux P, Tafani M.J

    Labelled Comp Radiopharm. 2015 Jun 15;58(7):274-80. doi: 10.1002/jlcr.3283.
  • > Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.

    Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, Vierron E, Vercouillie J, Ibazizene M, Voisin T, Payoux P, Barré L, Camus V, Guilloteau D, Ribeiro MJ.

    Biomed Res Int. 2015;2015:583931. doi: 10.1155/2015/583931.
  • > Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects.

    Jovicich J, Marizzoni M, Bosch B, Bartrés-Faz D, Arnold J, Benninghoff J, Wiltfang J, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Chanoine V, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Ragucci M, Soricelli A, Salvadori N, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Otto J, Reiss-Zimmermann M, Hoffmann KT, Galluzzi S, Frisoni GB; PharmaCog Consortium..

    Neuroimage. 2014 Nov 1;101:390-403. doi: 10.1016/j.neuroimage.2014.06.075.
  • > A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.

    Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J.

    J Alzheimers Dis. 2014;42(2):413-20. doi: 10.3233/JAD-140222.
  • > Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects.

    Nemmi F, Saint-Aubert L, Adel D, Salabert AS, Pariente J, Barbeau EJ, Payoux P, Péran P.

    Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1408-18. doi: 10.1007/s00259-014-2728-4.
  • > MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA.

    Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, Cuffi MN, Bordes S, Gasnier Y, Robert P, Bories L, Rouaud O, Desclaux F, Sudres K, Bonnefoy M, Pesce A, Dufouil C, Lehericy S, Chupin M, Mangin JF, Payoux P, Adel D, Legrand P, Catheline D, Kanony C, Zaim M, Molinier L, Costa N, Delrieu J, Voisin T, Faisant C, Lala F, Nourhashémi F, Rolland Y, Van Kan GA, Dupuy C, Cantet C, Cestac P, Belleville S, Willis S, Cesari M, Weiner MW, Soto ME, Ousset PJ, Andrieu S.

    J Prev Alzheimers Dis. 2014 Jun;1(1):13-22.
  • > Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.

    Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.

    Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8.